Processes for reducing the incidence of necrotic enterocolitis in a child and for the production of an enteral formula, and, improved enteral formulas containing arachidonic acid and docosahexaenoic acid and suitable for feeding children.

摘要

"PROCESSES TO REDUCE THE INCIDENCE OF NECROTIC ENTEROCOLITIS IN A CHILD AND FOR THE PRODUCTION OF AN ENTERAL FORMULA, AND, PERFECTED ENTERAL FORMULAS CONTAINING ARAQUIDANIC ACID AND SUITABLE FOOD DOCUMENTS." Enteral formulas, which contain long-chain polyunsaturated fatty acids (PUFAs), for example arachidonic acid (AA) and docosahexaenoic acid (DHA) essentially free from cholesterol, and a process for producing such enteral compositions are described. More particularly, the invention relates to processes for reducing the incidence of necrotic enterocolitis by administering compositions which provide n-6 and n-3 long-chain PUFAs; phospholipids and / or choline. Egg yolk compositions and lipids are presently preferred, as they contain n-6 and n-3 long-chain PUFAs and are predominantly in a phosphididylcholine form. This is believed to provide a synergistic effect. a process for producing such a composition that provides improved organoleptic and stability properties is also disclosed.